Multifocal thrombophlebitis and deep vein thrombosis in primary cytomegalovirus infection – A histopathological analysis

• References

• 1 Abgueguen P, Delbos V, Chennebault J. et al. Vascular thrombosis and acute cytomegalovirus infection in immunocompetent patients: report of 2 cases and literature review. Clin Infect Dis 2003; 36: E 134-139.
• 2 Youd P, Main J, Jackson E. Cytomegalovirus infection and thrombosis: a causative association?. J Infect 2003; 46: 141-142.
• 3 Kazory A, Ducloux D, Coaquette A. et al. Cytomegalovirus-associated venous thromboembolism in renal transplant recipients: a report of 7 cases. Transplantation 2004; 77: 597-599.
• 4 Jenkins R, Peters B, Pinching A. Thromboembolic disease in AIDS is associated with cytomegalovirus disease. AIDS 1991; 5: 1540-1542.
• 5 Spano L, Gatti J, Nascimento J, Leite J. Prevalence of human cytomegalovirus infection in pregnant and non-pregnant women. J Infect 2004; 48: 213-220.
• 6 Biedermann B, Sahner S, Gregor M. et al. Endothelial injury mediated by cytotoxic T lymphocytes and loss of microvessels in chronic graft versus host disease. Lancet 2002; 359: 2078-2083.
• 7 Jeanneret C, Baldi T, Hailemariam S. et al. Selective loss of extracellular matrix proteins is linked to biophysical properties of varicose veins assessed by ultrasonography. Br J Surg 2007; 94: 449-456.
• 8 Weinberg A, Zhang L, Hayward A. Alloreactive cytotoxic CD4+ responses elicited by cytomegalovirusinfected endothelial cells: role of MHC class I antigens. Viral Immunol 2000; 13: 37-47.
• 9 Waldman W, Knight D, Adams P. Cytolytic activity against allergenic human endothelia: resistance of cytomegalovirus-infected cells and virally activated lysis of uninfected cells. Transplantation 1998; 66: 67-77.
• 10 Kammer A, Van der Burg S, Grabscheid B. et al. Molecular mimicry of human cytochrome P450 by hepatitis C virus at the level of cytotoxic T cell recognition. J Exp Med 1999; 190: 169-176.
• 11 Holtappels R, Gillert-Marien D, Thomas D. et al. Cytomegalovirus encodes a positive regulator of antigen presentation. J Virol 2006; 80: 7613-7624.
• 12 Vercellotti G. Effects of viral activation of the vessel wall on inflammation and thrombosis. Blood Coagul Fibrinolysis 1998; 9: S3-S6.
• 13 Virchow R. Gesammelte Abhandlungen zur Wissenschaftlichen Medicin. Thrombosis and Emboli Virchow. Frankfurt: Meidinger Sohn & Co; 1856
• 14 Visseren FLJ, Bouwman JJM, Bouter KP. et al. Procoagulant Activity of Endothelial Cells after Infection with Respiratory Viruses. Thromb Haemost 2000; 84: 319-324.
• 15 van Dam-Mieras M, Muller A, van Hinsbergh V. et al. The procoagulant response of cytomegalovirus infected endothelial cells. Thromb Haemost 1992; 68: 364-370.
• 16 Squizzato A, Gerdes V, Büller HR. Effects of human cytomegalovirus infection on the coagulation system. Thromb Haemost 2005; 93: 403-410.